Patents by Inventor Andrew Remppis

Andrew Remppis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Short peptides for enhancing muscle function
    Patent number: 9453053
    Abstract: The present invention relates to shortened peptides comprising a muscle function enhancing amino acid sequence which is derived from the S100 calcium binding protein family. Furthermore, the present invention provides said peptides for medical use, in particular, for treating or preventing disorders associated with muscular malfunction, such as skeletal muscle or cardiac muscle disorders. The present invention also provides a pharmaceutical compositions comprising said peptides and a method for treating or preventing disorders associated with muscular malfunction using said peptides or said pharmaceutical compositions.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: September 27, 2016
    Assignee: UNIVERSITAT HEIDELBERG
    Inventors: Patrick Most, Mirko Voelkers, Hugo Katus, Andrew Remppis
  • Muscle function enhancing peptide
    Patent number: 9428564
    Abstract: The present invention relates to a peptide comprising a muscle function enhancing amino acid sequence which is derived from the S100 calcium binding protein family. Furthermore, the present invention provides said peptide for medical use, in particular, for treating or preventing disorders associated with muscular malfunction, such as skeletal muscle or cardiac muscle disorders. The present invention also provides a pharmaceutical composition comprising said peptide and a method for treating or preventing disorders associated with muscular malfunction using said peptide or said pharmaceutical composition.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: August 30, 2016
    Assignee: Universitatsklinikum Heidelberg
    Inventors: Patrick Most, Mirko Voelkers, Hugo Katus, Andrew Remppis
  • SHORT PEPTIDES FOR ENHANCING MUSCLE FUNCTION
    Publication number: 20130288971
    Abstract: The present invention relates to shortened peptides comprising a muscle function enhancing amino acid sequence which is derived from the S100 calcium binding protein family. Furthermore, the present invention provides said peptides for medical use, in particular, for treating or preventing disorders associated with muscular malfunction, such as skeletal muscle or cardiac muscle disorders. The present invention also provides a pharmaceutical compositions comprising said peptides and a method for treating or preventing disorders associated with muscular malfunction using said peptides or said pharmaceutical compositions.
    Type: Application
    Filed: October 20, 2011
    Publication date: October 31, 2013
    Applicant: UNIVERSITÄT HEIDELBERG
    Inventors: Patrick Most, Mirko Voelkers, Hugo Katus, Andrew Remppis
  • MUSCLE FUNCTION ENHANCING PEPTIDE
    Publication number: 20120129758
    Abstract: The present invention relates to a peptide comprising a muscle function enhancing amino acid sequence which is derived from the S100 calcium binding protein family. Furthermore, the present invention provides said peptide for medical use, in particular, for treating or preventing disorders associated with muscular malfunction, such as skeletal muscle or cardiac muscle disorders. The present invention also provides a pharmaceutical composition comprising said peptide and a method for treating or preventing disorders associated with muscular malfunction using said peptide or said pharmaceutical composition.
    Type: Application
    Filed: April 16, 2010
    Publication date: May 24, 2012
    Applicant: Universitatsklinikum Heidelberg
    Inventors: Patrick Most, Mirko Voelkers, Hugo Katus, Andrew Remppis
  • Treatment of cardiac power failure
    Patent number: 7588756
    Abstract: The invention relates to medicaments for treating cardiac power failure. The medicaments contain a therapeutically effective quantity of one or more S100 protein(s) or one or more mutant or fragments of the same, or contain one or more nucleic acid sequence(s) which code(s) for these amino acid sequences and which are optionally integrated in one or more gene transfer vectors.
    Type: Grant
    Filed: March 20, 2000
    Date of Patent: September 15, 2009
    Inventors: Hugo A. Katus, Andrew Remppis, Patrick Most